Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HTB | EGBN |
|---|---|---|
| Price | $46.13 | $28.03 |
| Change today | ▼ 0.73% | ▼ 0.74% |
| Market cap | $762.70M | $854.47M |
| Return, 3 months | -3.9% | +4.5% |
| Return, year to date | +8.4% | +31.0% |
| Return, 1 year | +16.5% | +34.0% |
| P/E (TTM) | 12.1 | -17.6 |
| P/B | 1.3 | 0.7 |
| P/E percentile vs own 5y | 62nd | 13th |
| Dividend yield | 1.15% | 0.70% |
| Revenue growth (YoY, latest qtr) | +1.0% | -1.5% |
| Net profit growth (YoY) | -9.2% | +109.9% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 29.9% | -16.1% |
| Return on equity | 10.9% | -4.1% |
| Analyst target vs. price | +19.2% | +12.4% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 44 | 49 |
| 30-day volatility | 16.5% | 18.0% |
| Max drawdown, 1 year | -12.5% | -26.6% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
